Knowles' Audio Components Business May Finally Reveal Whether AI Devices Create Real Demand

Knowles Corporation (KN) reports second-quarter 2026 earnings after the close on July 23, 2026, with analysts expecting $0.24 per share—a significant improvement from the $0.19 reported in the same quarter last year. The central question is whether the micro-acoustic and audio solutions specialist can sustain the momentum from four consecutive earnings beats while navigating a shifting technical picture that has seen its Barchart Opinion signal weaken from 100% Buy a month ago to just 40% Buy today.

Part 1: Earnings Preview

Knowles Corporation designs and manufactures advanced micro-acoustic microphones and balanced armature speakers, serving premium audio, hearing health, and consumer electronics markets. The company's precision components are critical to smartphones, hearables, and medical devices, making it a key supplier in the miniaturized audio technology space.

Knowles is scheduled to report second-quarter results after the close on July 23, 2026, with the consensus estimate calling for $0.24 per share. The company most recently reported $0.18 per share for the first quarter of 2026, which beat expectations by 28.57%. The upcoming estimate represents 26.32% year-over-year growth compared to the $0.19 reported in Q2 2025, signaling expectations for continued recovery in the company's core markets.

Three key themes define this earnings story:

AI-Driven Audio Demand: The explosion of AI applications—particularly voice-enabled agents and conversational interfaces—is creating new demand vectors for Knowles' precision microphones. OpenAI's recent launch of Presence, an enterprise AI agent platform handling voice interactions at scale, exemplifies the growing need for high-quality audio capture in AI systems. As enterprises deploy voice-based AI agents for customer support and internal workflows, demand for advanced microphone arrays and audio processing components could accelerate.

Hearables Market Evolution: The premium hearables segment continues to expand beyond traditional earbuds into health monitoring and hearing augmentation. Knowles' balanced armature technology remains the gold standard for high-fidelity audio in compact form factors, positioning the company to benefit from product cycles in both consumer and medical hearing devices.

Margin Recovery Trajectory: After reporting strong margin expansion in recent quarters, investors will scrutinize whether Knowles can maintain pricing discipline and operational efficiency as it scales production to meet recovering demand across its end markets.

Analyst commentary ahead of the release reflects cautious optimism. The single analyst covering the stock raised the Q2 estimate from $0.19 to $0.24 over the past quarter, suggesting improving visibility into demand trends. However, the next quarter's estimate was revised down from $0.27 to $0.25, indicating some uncertainty about the sustainability of near-term momentum. The full-year 2026 estimate of $0.94 implies 18.99% growth, with further acceleration to $1.14 (+21.28%) expected in 2027.

Part 2: Historical Earnings Performance

Knowles has established a consistent pattern of exceeding expectations, delivering four consecutive earnings beats with an average surprise of 12.95%. The trend shows improving execution: the company beat by 11.76% in Q2 2025, followed by 8.00% in Q3, 3.45% in Q4, and most recently a substantial 28.57% beat in Q1 2026.

The magnitude of beats has been meaningful but measured in the middle quarters, ranging from $0.01 to $0.02 per share, before the Q1 2026 result delivered a $0.04 upside surprise. This pattern suggests management has been conservative in guiding expectations while operational execution has steadily improved. The sequential EPS progression from $0.19 (Q2 2025) to $0.27 (Q3) to $0.30 (Q4) before the seasonal dip to $0.18 (Q1 2026) reflects both the company's typical quarterly cadence and underlying business momentum.

With the current $0.24 estimate representing a 26.32% year-over-year increase, investors will be watching whether Knowles can maintain its beat streak while also providing guidance that supports the $0.25 estimate for Q3 2026.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Knowles typically reports after market close, meaning Day 0 captures anticipatory trading before results are released, while Day +1 represents the first full session where the market digests actual results.

Historical price action shows significant volatility around Knowles earnings releases, with Day +1 moves averaging 3.59% in absolute terms and intraday ranges averaging 7.48%. The most dramatic reactions have occurred on Day +1, including a +9.27% surge following the July 2025 report and a +9.05% jump after February 2026 results—both sessions where the market had a full day to process better-than-expected results.

Day 0 moves have been more modest, averaging 2.37%, which is consistent with after-hours reporting where initial reactions are muted. However, the Day 0 range of 3.83% indicates meaningful intraday volatility as traders position ahead of the announcement. The most recent earnings (April 2026) saw a +2.42% Day 0 move followed by a -2.11% Day +1 pullback, suggesting some profit-taking after the initial positive reaction.

The pattern suggests investors should prepare for potential mid-to-high single-digit percentage swings in the session following results, with the direction heavily dependent on both the earnings beat/miss and forward guidance quality.

Part 2.2: Options Market Expected Move

The options market is currently pricing no expected move for the August expiration (30 days out), which appears to be a data anomaly given the stock's historical earnings volatility. Based on the eight-quarter average Day +1 move of 3.59% and average range of 7.48%, investors should anticipate meaningful post-earnings price action regardless of the options market signal.

Part 3: What Analysts Are Saying

Analysts maintain a bullish stance on Knowles with an average rating of 4.20 (Buy), though sentiment has deteriorated from 4.60 a month ago. The current consensus includes 3 Strong Buy ratings and 2 Hold ratings, with no sell recommendations. However, the shift from 4 Strong Buys to 3 over the past month, combined with one Hold rating being added, reflects some caution creeping into the analyst community.

The average price target of $36.25 sits essentially at the current price of $36.61, implying minimal upside from current levels. The range of targets spans from $33.00 to $39.00, suggesting analysts see limited downside risk (roughly 10%) but also capped near-term upside (about 7%) based on current valuations. This tight clustering around the current price indicates the market has largely priced in the expected earnings improvement, placing greater emphasis on guidance and commentary about future quarters.

The deterioration in sentiment despite the company's strong recent execution suggests analysts may be concerned about valuation after the stock's run from the $28 level (200-day moving average) or anticipating headwinds in the back half of 2026, as reflected in the downward revision to Q3 estimates.

Part 4: Technical Picture

Knowles enters earnings with a weakening technical picture despite trading well above its longer-term moving averages. The Barchart Technical Opinion has deteriorated sharply from 100% Buy a month ago to 56% Buy last week and now just 40% Buy, signaling eroding momentum as the stock approaches its quarterly report.

Timeframe Analysis:

• Short-term (Hold): Neutral signal indicates near-term momentum has stalled after the recent decline
• Medium-term (50% Buy): Moderate buy signal suggests the intermediate trend remains constructive but losing strength
• Long-term (100% Buy): Strong buy signal reflects the stock's substantial advance from lower levels over the past year

The trend is characterized as Good strength but in its Weakest direction, indicating the underlying uptrend remains intact but is currently under pressure.

The stock at $36.61 trades above its 5-day ($35.98), 10-day ($36.28), 100-day ($32.85), and 200-day ($28.27) moving averages, confirming the longer-term uptrend remains healthy. However, the price has slipped below both the 20-day ($37.49) and 50-day ($37.75) moving averages, technical breakdowns that often signal short-term momentum shifts.

The $37.49-$37.75 zone (20-day and 50-day moving averages) now represents immediate resistance, while the rising 10-day average at $36.28 provides nearby support. The stock's 29.6% gain above its 200-day moving average demonstrates the magnitude of the rally from last year's lows, but the recent failure at the 50-day average suggests some consolidation or profit-taking ahead of the report. The technical setup is cautiously neutral—the long-term trend remains supportive, but the short-term deterioration in momentum indicators suggests the stock may need a strong earnings beat and robust guidance to break back above resistance and resume its uptrend. A disappointment could see the stock test support at the 10-day average or potentially the 100-day at $32.85.